Literature DB >> 2126692

Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis.

C E Chenoweth1, K A Robinson, D R Schaberg.   

Abstract

Lethal enterococcal peritonitis in mice was used to compare trimethoprim-sulfamethoxazole (TMP-SMX) therapy with ampicillin therapy. Peritoneal fluid showed a 10(3)-CFU decrease in enterococci with ampicillin compared with TMP-SMX. Mortality of the untreated mice was 100%, compared with 40% for ampicillin and 95% for TMP-SMX, despite adequately measured levels in serum and peritoneal fluid.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2126692      PMCID： PMC171930          DOI： 10.1128/AAC.34.9.1800

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.

Authors:  M J Zervos; C A Kauffman; P M Therasse; A G Bergman; T S Mikesell; D R Schaberg
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

2.  Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.

Authors:  B E Murray; D A Church; A Wanger; K Zscheck; M E Levison; M J Ingerman; E Abrutyn; B Mederski-Samoraj
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

3.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

4.  Spectrofluorimetric method for the determination of trimethoprim in body fluids.

Authors:  D E Schwartz; B A Koechlin; R E Weinfeld
Journal:  Chemotherapy       Date:  1969       Impact factor: 2.544

5.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

6.  High-performance liquid chromatographic analysis of trimethoprim and sulfamethoxazole in dosage forms.

Authors:  R O Singletary; F D Sancilio
Journal:  J Pharm Sci       Date:  1980-02       Impact factor: 3.534

7.  Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice.

Authors:  Y Ike; H Hashimoto; D B Clewell
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

8.  Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.

Authors:  S R Crider; S D Colby
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

9.  In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.

Authors:  G L Goodhart
Journal:  JAMA       Date:  1984-11-16       Impact factor: 56.272

10.  Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid.

Authors:  M J Zervos; D R Schaberg
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191
View more
  16 in total

1.  Characterization of dihydrofolate reductase genes from trimethoprim-susceptible and trimethoprim-resistant strains of Enterococcus faecalis.

Authors:  T M Coque; K V Singh; G M Weinstock; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Septicemia due to susceptible Enterococcus faecalis despite prophylaxis with trimethoprim-sulfamethoxazole.

Authors:  H A Elsner; W Krüger; R Laufs; D Mack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 3.267

Review 3.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 4.  Diversity among multidrug-resistant enterococci.

Authors:  B E Murray
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

Review 5.  Adaptation to Adversity: the Intermingling of Stress Tolerance and Pathogenesis in Enterococci.

Authors:  Anthony O Gaca; José A Lemos
Journal:  Microbiol Mol Biol Rev       Date:  2019-07-17       Impact factor: 11.056

6.  Efficacy of Tedizolid against Enterococci and Staphylococci, Including cfr + Strains, in a Mouse Peritonitis Model.

Authors:  Kavindra V Singh; Cesar A Arias; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

7.  A simple model host for identifying Gram-positive virulence factors.

Authors:  D A Garsin; C D Sifri; E Mylonakis; X Qin; K V Singh; B E Murray; S B Calderwood; F M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

8.  Lack of homology of enterococci which have high-level resistance to trimethoprim with the dfrA gene of Staphylococcus aureus.

Authors:  M Frosolono; S L Hodel-Christian; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

9.  Genetic and Phenotypic Characteristics of a Multi-strain Probiotic for Broilers.

Authors:  Deon P Neveling; Jayesh J Ahire; Wikus Laubscher; Marina Rautenbach; Leon M T Dicks
Journal:  Curr Microbiol       Date:  2019-12-12       Impact factor: 2.188

Review 10.  Mechanisms of antibiotic resistance in enterococci.

Authors:  William R Miller; Jose M Munita; Cesar A Arias
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.